225 related articles for article (PubMed ID: 35345377)
1. Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Saavedra JA; Novo DR; Mesko MF; Uchoa Vasconcellos AC; Duarte Da Silva K; Rojas Zuñiga G; Ramires RF; Tarquinio SBC
Asian Pac J Cancer Prev; 2022 Mar; 23(3):1031-1039. PubMed ID: 35345377
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
3. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma.
Qian L; Qian B; Xu J; Yang J; Wu G; Zhao Y; Liu Q; Yuan Z; Fan Y; Li H
BMC Oral Health; 2023 Apr; 23(1):200. PubMed ID: 37013557
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Sankari SL; Mahalakshmi K; Kumar VN
BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews.
Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644
[TBL] [Abstract][Full Text] [Related]
7. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
8. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
11. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - A systematic review.
Piyarathne NS; Rasnayake RMSGK; Angammana R; Chandrasekera P; Ramachandra S; Weerasekera M; Yasawardene S; Abu-Eid R; Jayasinghe JAP; Gupta E
Expert Rev Mol Diagn; 2021 Aug; 21(8):789-807. PubMed ID: 34148471
[TBL] [Abstract][Full Text] [Related]
13. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
14. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
[TBL] [Abstract][Full Text] [Related]
15. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
[TBL] [Abstract][Full Text] [Related]
17. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
18. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
19. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
Abdelwhab A; Shaker O; Aggour RL
Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
[TBL] [Abstract][Full Text] [Related]
20. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
